Figures
Study participant flow diagram.
Tables

Details of the Trigger Point Dry Needling Intervention Implemented in the Trial Consistent With STRICTA Recommendationsa
↵a STRICTA=STandards for Reporting Interventions in Clinical Trials of Acupuncture, MTrP=myofascial trigger point.
b Seirin Corp, 13-7 Yokosuna-Nishicho, Shimizu-ku, Shizuoka City, Shizuoka 424-0036, Japan.
c Suzhou Medical Appliance Factory, 14 West Qi Lin Lance, Suzhou, China.

Baseline Characteristics of Participants for Intervention Groupsa
↵a Values are mean (SD) unless stated otherwise.
b A comorbidity was defined as any medical condition reported by a participant for which he or she was taking medication.
c VAS=visual analog scale (higher values indicate greater levels of heel pain when getting out of bed in the morning).
d FHSQ=Foot Health Status Questionnaire (0=“worst foot health,” 100=“best foot health”).
e SF-36=36-Item Short-Form Health Survey (0=“worst quality of life,” 100=“best quality of life”).
f DASS-21= 21-item short-form Depression, Anxiety and Stress Scale (higher scores indicate more symptoms).
g PAR=Physical Activity Recall Questionnaire (values correspond to total weekly energy expenditure in kcal/kg/wk).

Mean Scores and Mean Difference Between Groups for Primary Outcome Measuresa
↵a Values are mean (SD) unless stated otherwise. 95% CI=95% confidence interval. Primary end-point results, nominated prior to the commencement of the trial, are highlighted in bold type. *Statistically significant at P<.05.
b VAS=visual analog scale (higher values indicate greater levels of heel pain when getting out of bed in the morning).
c FHSQ=Foot Health Status Questionnaire (0=“worst foot health,” 100=“best foot health”).

Mean Scores and Mean Difference Between Groups for Secondary Outcome Measures at 6 and 12 Weeksa
↵a Data are expressed as mean (SD) unless stated otherwise. *Statistically significant at P<.05.
b FHSQ=Foot Health Status Questionnaire (0=“worst foot health,” 100= “best foot health”).
c SF-36=36-Item Short-Form Health Survey (0=“worst quality of life,” 100=“best quality of life”).
d DASS-21=21-item short-form Depression, Anxiety and Stress Scale (higher scores indicate more symptoms).
Supplementary Data
eTables
Files in this Data Supplement:
- eTables (PDF) (23 KB) -
This PDF contains the following eTables:
- eTable 1. Participant-Reported Use of Cointerventions and Pain-Relieving Medication During the Trial
- eTable 2. Assessments of Treatment Expectancy and Rationale Credibility Recorded After the First Treatment